作者
Ryan A. Blaustein,Zeyang Shen,Sara Saheb Kashaf,Shih-Queen Lee-Lin,Sean Conlan,Marita Bosticardo,Ottavia M. Delmonte,Cassandra J. Holmes,Monica E. Taylor,Glenna Banania,Keisuke Nagao,Dimana Dimitrova,Jennifer A. Kanakry,Helen C. Su,Steven M. Holland,Jenna Bergerson,Alexandra F. Freeman,Luigi D. Notarangelo,Julia A. Segre,Julia A. Segre,Jim Thomas,James C. Mullikin,Alice C. Young,Gerry Bouffard,Betty Barnabas,Shelise Brooks,Christian Büchter,Jacob E. Crawford,Joel Han,Shi-ling Ho,Richelle Legaspi,Quino Maduro,Holly Marfani,Casandra Montemayor,Karen Schandler,Brian Schmidt,Christina Sison,Mal Stantripop,Sean Black,Mila Dekhtyar,Cathy Masiello,Jenny McDowell,Morgan Park,Pam Thomas,Meg Vemulapalli
摘要
The complex interplay between microbiota and immunity is important to human health. To explore how altered adaptive immunity influences the microbiome, we characterize skin, nares, and gut microbiota of patients with recombination-activating gene (RAG) deficiency—a rare genetically defined inborn error of immunity (IEI) that results in a broad spectrum of clinical phenotypes. Integrating de novo assembly of metagenomes from RAG-deficient patients with reference genome catalogs provides an expansive multi-kingdom view of microbial diversity. RAG-deficient patient microbiomes exhibit inter-individual variation, including expansion of opportunistic pathogens (e.g., Corynebacterium bovis, Haemophilus influenzae), and a relative loss of body site specificity. We identify 35 and 27 bacterial species derived from skin/nares and gut microbiomes, respectively, which are distinct to RAG-deficient patients compared to healthy individuals. Underscoring IEI patients as potential reservoirs for viral persistence and evolution, we further characterize the colonization of eukaryotic RNA viruses (e.g., Coronavirus 229E, Norovirus GII) in this patient population.